Marcus A. Neubauer
Marcus A. Neubauer publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics, on topics such as Lung Cancer Treatments and Mutations, Economic and Financial Impacts of Cancer and Lung Cancer Diagnosis and Treatment.
- World rank
- #1,196,906 of 7,710,434 ranked researchers
- Rank in United States
- #383,991 of 1,627,098
- Works
- 103
- Citations
- 2.6k
- Citations per work
- 25.1
What does Marcus A. Neubauer research?
Marcus A. Neubauer's work is mostly in Medicine (58%), Economics, Econometrics and Finance (16%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5957.6%
- Medicine5957.6%
- Everything else1918.3%
- Social Sciences1615.9%
- Life Sciences88.2%
- 1Oncology28% of their works
- 2Pulmonary and Respiratory Medicine23% of their works
- 3Economics and Econometrics16% of their works
- 4Public Health, Environmental and Occupational Health6% of their works
- 5Cancer Research5% of their works
- 6Molecular Biology3% of their works
Research topics
Which keywords describe Marcus A. Neubauer's research?
The keywords of their largest research topics: Chemotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Quality of Life, Cost of Care and Financial Toxicity.
- Febrile Neutropenia
- Health Utility Measures
- Small-Cell Lung Cancer
- KRAS Mutations
- Taxanes
- Lung Cancer
- Financial Toxicity
- Quality of Life
- ALK Inhibitors
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- EGFR Mutations
- Cost of Care
- CT Screening
- Chemotherapy-Induced Peripheral Neuropathy
- Cetuximab
- Genomic Profiles
- Cost-effectiveness Analysis
- Antimicrobial Agents
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy654 topics
- Clinical Trials552 topics
- Targeted Therapy552 topics
- ALK Inhibitors381 topic
- EGFR Mutations381 topic
- Quality of Life342 topics
- Cost of Care321 topic
- Financial Toxicity321 topic
- CT Screening221 topic
- Lung Cancer221 topic
- Chemotherapy-Induced Peripheral Neuropathy211 topic
- Taxanes211 topic
- Cetuximab181 topic
- KRAS Mutations181 topic
- Genomic Profiles171 topic
- Small-Cell Lung Cancer171 topic
- Cost-effectiveness Analysis131 topic
- Health Utility Measures131 topic
- Antimicrobial Agents81 topic
- Febrile Neutropenia81 topic
Where does Marcus A. Neubauer work?
Marcus A. Neubauer's main affiliation in the publication record is Texas Oncology, United States.
How many publications and citations does Marcus A. Neubauer have?
OpenAlex counts 103 works and 2,586 citations for Marcus A. Neubauer, an h-index of 23, ranking #1,196,906 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Marcus A. Neubauer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.